Lyell Immunopharma (LYEL) Net Margin (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Lyell Immunopharma | 379.11 Mn | 379.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.06 Mn |
| Dec 31, 2025 | -185.62 Mn |
| Sep 30, 2025 | 32.17 Mn |
| Jun 30, 2025 | 21.61 Mn |
| Mar 31, 2025 | 101.95 Mn |
| Dec 31, 2024 | -165.29 Mn |
| Sep 30, 2024 | 21.64 Mn |
| Jun 30, 2024 | 127.78 Mn |
| Mar 31, 2024 | -122.19 Mn |
| Dec 31, 2023 | -19.35 Mn |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | -13.53 Mn |
| Mar 31, 2023 | -8.93 Mn |
| Dec 31, 2022 | 213.95 Mn |
| Sep 30, 2022 | -213.94 Mn |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | -1.07 Mn |
| Dec 31, 2021 | 10,152.00 |
| Sep 30, 2021 | 60,319.00 |
| Jun 30, 2021 | -12,767.00 |
| Mar 31, 2021 | -56,749.00 |
| Dec 31, 2020 | 165,819.00 |
| Sep 30, 2020 | -11,169.00 |